Page last updated: 2024-08-25

bendamustine hydrochloride and Leukemia, Hairy Cell

bendamustine hydrochloride has been researched along with Leukemia, Hairy Cell in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Imoto, N; Koyama, D; Kurahashi, S; Sugiura, I1
Li, HC; Sadeghi, N1
Doll, D; Letendre, P1
Arons, E; Burotto, M; Kreitman, RJ; Stetler-Stevenson, M; Wilson, W; Zhou, H1
Arons, E; Kreitman, RJ; Miller, KB; Stetler-Stevenson, M1

Other Studies

5 other study(ies) available for bendamustine hydrochloride and Leukemia, Hairy Cell

ArticleYear
Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report.
    Medicine, 2021, Feb-05, Volume: 100, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Rituximab

2021
MRD-negative complete remission in relapsed refractory hairy cell leukemia with bendamustine and obinutuzumab.
    Annals of hematology, 2018, Volume: 97, Issue:4

    Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Bendamustine Hydrochloride; Female; Humans; Leukemia, Hairy Cell; Remission Induction

2018
Novel therapeutics in the treatment of hairy cell leukemia variant.
    Leukemia research, 2018, Volume: 75

    Topics: Adenine; Aged; Aged, 80 and over; Antineoplastic Agents; Bendamustine Hydrochloride; Female; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Piperidines; Pyrazoles; Pyrimidines; Rituximab

2018
Bendamustine and rituximab in relapsed and refractory hairy cell leukemia.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Nov-15, Volume: 19, Issue:22

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Blood Platelets; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Administration Schedule; Female; Humans; Immunologic Factors; Leukemia, Hairy Cell; Lymphocyte Count; Male; Middle Aged; Nitrogen Mustard Compounds; Pilot Projects; Platelet Count; Remission Induction; Rituximab; Treatment Outcome

2013
Response of hairy cell leukemia to bendamustine.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:6

    Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Humans; Interleukin-2 Receptor alpha Subunit; Leukemia, Hairy Cell; Male; Middle Aged; Nitrogen Mustard Compounds; Sialic Acid Binding Ig-like Lectin 2; Treatment Outcome; Tumor Burden

2011